Literature DB >> 20628864

[Circulating cell-free serum DNA: significance as a new biomarker for urological malignancies].

J Ellinger1, A von Rücker, P J Bastian, S C Müller.   

Abstract

The presence of circulating cell-free DNA was demonstrated already in the 1940s. Improved detection methods have led to increased knowledge on cell-free DNA, and recent studies showed that most cancer patients have increased levels of cell-free DNA. Measurement of cell-free DNA allowed sensitive and specific discrimination between cancer patients and those with non-malignant diseases.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20628864     DOI： 10.1007/s00120-010-2342-4

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  22 in total

1.  Circulating mitochondrial nucleic acids have prognostic value for survival in patients with advanced prostate cancer.

Authors:  Niven Mehra; Maarten Penning; Jolanda Maas; Nancy van Daal; Rachel H Giles; Emile E Voest
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

2.  Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer.

Authors:  Annalisa Altimari; Antonia D'Errico Grigioni; Elisa Benedettini; Elena Gabusi; Riccardo Schiavina; Antonio Martinelli; Antonio Maria Morselli-Labate; Giuseppe Martorana; Walter Franco Grigioni; Michelangelo Fiorentino
Journal:  Am J Clin Pathol       Date:  2008-05       Impact factor: 2.493

Review 3.  [Value of biomarkers in urology].

Authors:  P J Goebell; B Keck; S Wach; B Wullich
Journal:  Urologe A       Date:  2010-04       Impact factor: 0.639

4.  Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators.

Authors:  Jörg Ellinger; Patrick J Bastian; Kim I Haan; Lukas C Heukamp; Reinhard Buettner; Rolf Fimmers; Stefan C Mueller; Alexander von Ruecker
Journal:  Int J Cancer       Date:  2008-01-01       Impact factor: 7.396

5.  Prospective study of quantitation of plasma DNA levels in the diagnosis of malignant versus benign prostate disease.

Authors:  Jane L Boddy; Shira Gal; Peter R Malone; Adrian L Harris; Jim S Wainscoat
Journal:  Clin Cancer Res       Date:  2005-02-15       Impact factor: 12.531

6.  Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.

Authors:  Patrick J Bastian; Ganesh S Palapattu; Srinivasan Yegnasubramanian; Xiaohui Lin; Craig G Rogers; Leslie A Mangold; Bruce Trock; Mario Eisenberger; Alan W Partin; William G Nelson
Journal:  Clin Cancer Res       Date:  2007-09-15       Impact factor: 12.531

7.  CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.

Authors:  Jörg Ellinger; Peter Albers; Frank G Perabo; Stefan C Müller; Alexander von Ruecker; Patrick J Bastian
Journal:  J Urol       Date:  2009-05-17       Impact factor: 7.450

8.  Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.

Authors:  Heidi Schwarzenbach; Catherine Alix-Panabières; Imke Müller; Nicolas Letang; Jean-Pierre Vendrell; Xavier Rebillard; Klaus Pantel
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

9.  Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy.

Authors:  Jörg Ellinger; Stefan C Müller; Nicolas Wernert; Alexander von Ruecker; Patrick J Bastian
Journal:  BJU Int       Date:  2008-04-11       Impact factor: 5.588

10.  Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: a prognostic entity.

Authors:  Jörg Ellinger; Patrick J Bastian; Nadja Ellinger; Philip Kahl; Frank G Perabo; Reinhard Büttner; Stefan C Müller; Alexander von Ruecker
Journal:  Cancer Lett       Date:  2008-03-10       Impact factor: 8.679
View more
  1 in total

Review 1.  Circulating Tumor DNA in Patients with Renal Cell Carcinoma. A Systematic Review of the Literature.

Authors:  Louise Geertsen; Kristina Magaard Koldby; Mads Thomassen; Torben Kruse; Lars Lund
Journal:  Eur Urol Open Sci       Date:  2022-01-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.